Loading clinical trials...
Loading clinical trials...
Effect of Sitagliptin on the Blood Pressure Response to ACE Inhibition in the Metabolic Syndrome
Conditions
Interventions
Placebo
Enalapril 5mg
+2 more
Locations
1
United States
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Start Date
March 1, 2008
Primary Completion Date
August 1, 2009
Completion Date
January 1, 2010
Last Updated
May 11, 2012
NCT02417740
NCT07480265
NCT07073820
NCT06876233
NCT07237750
NCT06062394
Lead Sponsor
Vanderbilt University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions